Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BelgiumStudy on FX06 for Improving Acute Respiratory Distress Syndrome in Patients
FranceStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
BelgiumStudy on Tezepelumab for Patients with Severe Asthma
FranceStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
BelgiumStudy on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
DenmarkStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
GermanyStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
AustriaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CroatiaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
